We are live on
!
Find out more
PAMS
Pictet Asset Management (Switzerland) Portfolio holdings
AUM
$84.3B
1-Year Est. Return
26.5%
This Fund
S&P 500
This Quarter
Est. Return
+10%
1 Year Est. Return
+26.5%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$69.2B
AUM Growth
+$1.83B
(+2.7%)
Cap. Flow
-$601M
Cap. Flow
% of AUM
-0.87%
Top 10 Holdings %
Top 10 Hldgs %
13.85%
Holding
2,040
New
475
Increased
982
Reduced
499
Closed
56
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Equinix
EQIX
|
+$171M |
| 2 |
Moderna
MRNA
|
+$147M |
| 3 |
Exelon
EXC
|
+$113M |
| 4 |
Waters Corp
WAT
|
+$91.6M |
| 5 |
ANSS
Ansys
ANSS
|
+$71.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Extra Space Storage
EXR
|
+$128M |
| 2 |
A.O. Smith
AOS
|
+$104M |
| 3 |
Enphase Energy
ENPH
|
+$93.8M |
| 4 |
Evergy
EVRG
|
+$81.1M |
| 5 |
Dominion Energy
D
|
+$80.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.93% |
| 2 | Healthcare | 17.36% |
| 3 | Industrials | 15.16% |
| 4 | Utilities | 11.76% |
| 5 | Consumer Discretionary | 8.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
826
Greif
GEF
$5.03B
| $3.41M | ﹤0.01% |
50,864
+550
| +1% | +$37.1K |
|
827
Alcoa
AA
$13.1B
| $3.41M | ﹤0.01% |
74,952
+16,841
| +29% | +$733K |
|
828
Whirlpool
WHR
$2.79B
| $3.4M | ﹤0.01% |
24,022
-1,466
| -6% | -$208K |
|
829
Enanta Pharmaceuticals
ENTA
$391M
| $3.39M | ﹤0.01% |
72,937
+18,840
| +35% | +$859K |
|
830
Roblox
RBLX
$27.1B
| $3.39M | ﹤0.01% |
119,041
-1,632
| -1% | -$57.3K |
|
831
HEICO Corp Class A
HEI.A
$38.1B
| $3.39M | ﹤0.01% |
28,255
-4,597
| -14% | -$561K |
|
832
Vanda Pharmaceuticals
VNDA
$304M
| $3.37M | ﹤0.01% |
456,617
+113,627
| +33% | +$1.11M |
|
|
DQ
833
Daqo New Energy
DQ
$1.01B
| $3.36M | ﹤0.01% |
86,975
+13,775
| +19% | +$674K |
|
834
ADC Therapeutics
ADCT
$134M
| $3.34M | ﹤0.01% |
868,838
-426,180
| -33% | -$1.7M |
|
835
Cognex
CGNX
$10.4B
| $3.33M | ﹤0.01% |
70,772
-768
| -1% | -$36K |
|
836
Autohome
ATHM
$2.6B
| $3.32M | ﹤0.01% |
108,500
+8,100
| +8% | +$241K |
|
837
Caesars Entertainment
CZR
$6.04B
| $3.31M | ﹤0.01% |
79,671
+1,848
| +2% | +$82.3K |
|
838
Lear
LEA
$8.16B
| $3.29M | ﹤0.01% |
26,545
+2,292
| +9% | +$304K |
|
839
Assurant
AIZ
$13.9B
| $3.29M | ﹤0.01% |
26,288
-16,773
| -39% | -$2.23M |
|
840
American Financial Group
AFG
$12.1B
| $3.26M | ﹤0.01% |
23,764
+99
| +0.4% | +$13.6K |
|
841
Wabtec
WAB
$50.3B
| $3.26M | ﹤0.01% |
2,056,762
-33,350
| -2% | -$3.19M |
|
|
GTM
842
ZoomInfo Technologies
GTM
$1.25B
| $3.24M | ﹤0.01% |
107,691
+4,707
| +5% | +$162K |
|
843
UGI
UGI
$7.56B
| $3.23M | ﹤0.01% |
87,144
-29,830
| -26% | -$1.08M |
|
844
Ally Financial
ALLY
$13.6B
| $3.21M | ﹤0.01% |
131,095
-8,334
| -6% | -$222K |
|
845
Liberty Broadband Class C
LBRDK
$5.29B
| $3.19M | ﹤0.01% |
41,833
-2,642
| -6% | -$215K |
|
|
JOYY
846
JOYY Inc
JOYY
$3.64B
| $3.17M | ﹤0.01% |
100,207
-3,300
| -3% | -$95.4K |
|
847
Entegris
ENTG
$25B
| $3.16M | ﹤0.01% |
48,172
-140
| -0.3% | -$10.3K |
|
848
Teva Pharmaceuticals
TEVA
$42.6B
| $3.15M | ﹤0.01% |
345,585
+8,300
| +2% | +$72.4K |
|
849
Dentsply Sirona
XRAY
$2.31B
| $3.14M | ﹤0.01% |
98,580
-5,451
| -5% | -$164K |
|
850
Knight Transportation
KNX
$11.9B
| $3.1M | ﹤0.01% |
59,136
-2,652
| -4% | -$137K |
|
Similar funds
TF
TAIM
V
PI
WI
VIA
EST
TCM
Pictet Asset Management (Switzerland)'s Q4 2022 Portfolio in Review
As of Q4 2022, Pictet Asset Management (Switzerland) held 2,040 positions worth $69.2B, up 2.7% from $67.4B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Pictet Asset Management (Switzerland)'s Q4 2022 filing shows 475 new, 982 increased, 499 reduced and 56 closed positions. Its largest new stake was Amylyx Pharmaceuticals: 1,121,765 shares worth $41.4M. The largest sale was Extra Space Storage, an estimated $128M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 25% a quarter earlier, followed by Healthcare and Industrials.
- Pictet Asset Management (Switzerland)'s largest Q4 2022 buy was Amylyx Pharmaceuticals: 1,121,765 shares worth $41.4M.
- Pictet Asset Management (Switzerland) added most to Equinix in Q4 2022, an estimated $171M increase.
- Pictet Asset Management (Switzerland)'s biggest Q4 2022 reduction was Extra Space Storage, cutting an estimated $128M.
- Pictet Asset Management (Switzerland) fully exited Nomad Foods in Q4 2022, selling an estimated $49.5M.
- Pictet Asset Management (Switzerland)'s ten largest holdings make up 14% of its $69.2B portfolio in Q4 2022.
- Pictet Asset Management (Switzerland) opened 475 new positions and closed 56 in Q4 2022.
- Pictet Asset Management (Switzerland)'s portfolio value rose 2.7% quarter-over-quarter to $69.2B.
Based on Pictet Asset Management (Switzerland)'s 13F filing for Q4 2022, filed 13 Feb 2023.